Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript.
about
Pre-clinical validation of a novel, highly sensitive assay to detect PML-RARalpha mRNA using real-time reverse-transcription polymerase chain reactionChemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells.A new method for high speed, sensitive detection of minimal residual disease.Leukocyte count affects expression of reference genes in canine whole blood samples.P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPAClinical applications of BCR-ABL molecular testing in acute leukemiaDetection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging.Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.Clinical Relevance of RUNX1 and CBFB Alterations in Acute Myeloid Leukemia and Other Hematological Disorders.DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412.Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR.Utility of a multiplex reverse transcriptase-polymerase chain reaction assay (HemaVision) in the evaluation of genetic abnormalities in Korean children with acute leukemia: a single institution study.Low miR-210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia.Minimal/measurable residual disease in AML: consensus document from ELN MRD Working Party.Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.A molecular signature of dormancy in CD34+CD38- acute myeloid leukaemia cells.Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease--a study within the Europe Against Cancer Program.TEL (ETV6)-AML1 (RUNX1) initiates self-renewing fetal pro-B cells in association with a transcriptional program shared with embryonic stem cells in mice.Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.Stability of cord blood RNA measured by house keeping transcripts: relevance for large-scale studies of childhood leukaemia.Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer.
P2860
Q28363005-D7C85C03-47E7-4ACC-8FEB-698F36CABB7FQ30671189-EE0EA58E-63A2-4D82-8F45-8C0A80428503Q31030896-FFEC8133-46B4-4ADA-AA53-18CE437FE0EAQ33814994-EB3D73F4-9C25-4DFE-A3DE-31D2F655825CQ33934534-F313D245-CD6A-4F39-B13A-5F47782E7465Q35111716-F8D17889-16EC-41CB-A28B-69278988A854Q35134983-636BABC1-9044-40D3-8E07-55CABF5B4455Q35561038-6B096EDD-556E-4E9B-AC33-56634D7CA63BQ36528412-2B04D818-5B6F-4736-9242-B37DA2F09E00Q37255343-61543840-F5FC-4857-9D59-011DE0855383Q37821356-D1F4D2F9-925C-4B33-B753-AA033454E47CQ38354341-8D2543F0-02B4-4794-908D-59F2E9753A84Q38359524-9FC60405-99B1-4260-A73D-96EEB51C1972Q38904250-8B3AEC14-CD4D-46D8-9DBF-368524EB111DQ40215417-63933F98-3CB7-42A2-A114-B7A7E021980AQ40821721-44A25F68-1AD4-423D-BA02-DEB17B97D3D6Q42016630-9055EC24-C3E4-4BF2-9A47-6B3DB5B43CBAQ47144324-B57073E4-636E-4C10-BD4C-E3697B84C49FQ47734674-4A8E88C0-28D1-42EC-8C8F-89C531299219Q48316021-3739925B-BF45-4B61-9E04-FBCEB5B01E1CQ49510072-68CEF6AF-05A4-4F3D-867B-418F88AA4A9EQ51039328-9DB8500A-CFF6-4424-ACDA-976137F91A89Q53135188-B41F4753-8C43-4791-93CB-039E863DEC88Q53645182-F95CCE1D-A034-4570-BFE8-05E8E9C1F87CQ54575586-B50FAD37-A45C-4F53-8ECC-86338FC21F32Q54631878-EBDA4D20-920F-4928-BB48-B1A01DDA4CC0Q54786477-DCC34D1C-EBC4-42E1-BA96-E2E2BAF04222
P2860
Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Rapid and sensitive minimal re ...... 1) TEL-AML1 fusion transcript.
@en
type
label
Rapid and sensitive minimal re ...... 1) TEL-AML1 fusion transcript.
@en
prefLabel
Rapid and sensitive minimal re ...... 1) TEL-AML1 fusion transcript.
@en
P2093
P2860
P1476
Rapid and sensitive minimal re ...... 1) TEL-AML1 fusion transcript.
@en
P2093
Pallisgaard N
Schroder H
P2860
P304
P356
10.1002/(SICI)1098-2264(199912)26:4<355::AID-GCC10>3.0.CO;2-3
P577
1999-12-01T00:00:00Z